Role of fumonisin B1 on DNA methylation changes in rat kidney and liver cells

References

• Abdel Nour AM, Ringot D, Gue'ant JL, Chango A. (2007). Folate receptor and human reduced folate carrier expression in HepG2 cell line exposed to fumonisin B1 and folate deficiency. Carcinogenesis 28:2291–7
   PubMedGoogle Scholar
• Abel S, Gelderblom WC. (1998). Oxidative damage and fumonisin B1-induced toxicity in primary rat hepatocytes and rat liver in vivo. Toxicology 131:121–31
   PubMed Web of Science ®Google Scholar
• Aranda M, Perez-Alzola LP, Ellahuene MF, Sepulveda C. (2000). Assessment of in vitro mutagenicity in Salmonella and in vivo genotoxicity in mice of the mycotoxin fumonisin B1. Mutagenesis 15:469–71
   PubMedGoogle Scholar
• Asada K, Asada R, Yoshiji H, et al. (2006). DNA cytosine methylation profile in various cancer-related genes is altered in cultured rat hepatocyte cell lines as compared with primary hepatocytes. Oncol Rep 15:1241–8
   PubMedGoogle Scholar
• Baccarelli A, Bollati V. (2009). Epigenetics and environmental chemicals. Curr Opin Pediatr 21:243–51
   PubMed Web of Science ®Google Scholar
• Baylin SB, Herman JG, Graff JR, et al. (1998). Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res 72:141–96
   PubMed Web of Science ®Google Scholar
• Bombail V, Moggs JG, Orphanides G. (2004). Perturbation of epigenetic status by toxicants. Toxicol Lett 149:51–8
   PubMed Web of Science ®Google Scholar
• Chen T, Mally A, Ozden S, Chipman JK. (2010). Low doses of the carcinogen furan alter cell cycle and apoptosis gene expression in rat liver independent of DNA methylation. Environ Health Perspect 118:1597–602
   PubMed Web of Science ®Google Scholar
• Chuturgoon AA, Phulukdaree A, Moodley D. (2014). Fumonisin B1 induces global DNA hypomethylation in HepG2 cells – An alternative mechanism of action. Toxicology 315:65–9
   PubMed Web of Science ®Google Scholar
• Domijan AM, Zeljezic D, Kopjar N, Peraica M. (2006). Standard and Fpg-modified comet assay in kidney cells of ochratoxin A- and fumonisin B1-treated rats. Toxicology 222:53–9
   PubMed Web of Science ®Google Scholar
• Domijan AM, Zeljezic D, Milic M, Peraica M. (2007). Fumonisin B(1): Oxidative status and DNA damage in rats. Toxicology 232:163–9
   PubMed Web of Science ®Google Scholar
• Domijan A, Zeljezic D, Peraica M, et al. (2008). Early toxic effects of fumonisin B1 in rat liver. Hum Exp Toxicol 27:895–900
   PubMed Web of Science ®Google Scholar
• Domijan AM, Abramov AY. (2011). Fumonisin B1 inhibits mitochondrial respiration and deregulates calcium homeostasis-implication to mechanism of cell toxicity. Int J Biochem Cell Biol 43:897–904
   PubMed Web of Science ®Google Scholar
• Du YP, Peng JS, Sun A, et al. (2009). Assessment of the effect of betaine on p16 and c-myc DNA methylation and mRNA expression in a chemical induced rat liver cancer model. BMC Cancer 9:1–9
   PubMedGoogle Scholar
• Esteller M. (2002). CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene 21:5427–40
   PubMed Web of Science ®Google Scholar
• Fragou D, Fragou A, Kouidou S, et al. (2011). Epigenetic mechanisms in metal toxicity. Toxicol Mech Methods 21:343–52
   PubMed Web of Science ®Google Scholar
• Frommer M, McDonald LE, Millar DS, et al. (1992). A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89:1827–31
   PubMed Web of Science ®Google Scholar
• Galvano F, Campisi A, Russo A, et al. (2002). DNA damage in astrocytes exposed to fumonisin B1. Neurochem Res 27:345–51
   PubMed Web of Science ®Google Scholar
• Gelderblom WCA, Kriek NPJ, Marasas WFO, Thiel PG. (1991). Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 12:1247–51
   PubMed Web of Science ®Google Scholar
• Gelderblom WC, Snyman SD. (1991). Mutagenicity of potentially carcinogenic mycotoxins produced by Fusarium moniliforme. Mycotoxin Res 7:46–52
   PubMedGoogle Scholar
• Gelderblom WC, Semple E, Marasas WF, Farber E. (1992). The cancer-initiating potential of the fumonisin B mycotoxins. Carcinogenesis 13:433–7
   PubMed Web of Science ®Google Scholar
• Gelderblom WC, Marasas WF, Lebepe-Mazur S, et al. (2008). Cancer initiating properties of fumonisin B1 in a short-term rat liver carcinogenesis assay. Toxicology 250:89–95
   PubMed Web of Science ®Google Scholar
• Gelderblom WC, Marasas WF. (2012). Controversies in fumonisin mycotoxicology and risk assessment. Hum Exp Toxicol 31:215–35
   PubMedGoogle Scholar
• Gelineau-van Waes J, Starr L, Maddox J, et al. (2005). Maternal fumonisin exposure and risk for neural tube defects: Mechanisms in an in vivo mouse model. Birth Defects Res 73:487–97
   PubMed Web of Science ®Google Scholar
• Harrison LR, Colvin BM, Greene JT, et al. (1990). Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme. J Vet Diagn Invest 2:217–21
   PubMedGoogle Scholar
• Herman JG, Graff JR, Myöhänen S, et al. (1996). Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821–6
   PubMed Web of Science ®Google Scholar
• Herman JG, Latif F, Weng Y, et al. (1994). Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700–4
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer. (2002). Fumonisin B1, IARC monographs on the evaluation of carcinogenic risks to humans: Some traditional medicines, some mycotoxins, naphthalene and styrene. IARC 82:301–66
   Google Scholar
• Jones PA, Baylin SB. (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–28
   PubMed Web of Science ®Google Scholar
• Kato A, Shimizu Y, Fujii H, et al. (2006). Aberrant DNA methylation of E-cadherin and p16 genes in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine. Mol Carcinog 45:106–11
   PubMed Web of Science ®Google Scholar
• Kellerman TS, Marasas WF, Thiel PG, et al. (1990). Leukoencephalomalacia in two horses induced by oral dosing of fumonisin B1. Onderstepoort J Vet Res 57:269–75
   PubMed Web of Science ®Google Scholar
• Knasmueller S, Bresgen N, Kassie F, et al. (1997). Genotoxic effects of three Fusarium mycotoxins, fumonisin B1, moniliformin and vomitoxin in bacteria and in primary cultures of rat hepatocytes. Mutat Res-Genet Toxicol Environ Mutagen 391:39–48
   Google Scholar
• Koturbash I, Beland FA, Pogribny IP. (2011). Role of epigenetic events in chemical carcinogenesis – A justification for incorporating epigenetic evaluations in cancer risk assessment. Toxicol Mech Methods 21:289–97
   PubMed Web of Science ®Google Scholar
• Kouadio JH, Dano SD, Moukha S, et al. (2007). Effects of combinations of Fusarium mycotoxins on the inhibition of macromolecular synthesis, malondialdehyde levels, DNA methylation and fragmentation, and viability in Caco-2 cells. Toxicon 49:306–17
   PubMed Web of Science ®Google Scholar
• Kouadio JH, Mobio TA, Baudrimont I, et al. (2005). Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology 213:56–65
   PubMed Web of Science ®Google Scholar
• LeBaron MJ, Rasoulpour RJ, Klapacz J, et al. (2010). Epigenetics and chemical safety assessment. Mutat Res 705:83–95
   PubMed Web of Science ®Google Scholar
• Li LC, Dahiya R. (2002). MethPrimer: Designing primers for methylation PCRs. Bioinformatics 18:1427–31
   PubMed Web of Science ®Google Scholar
• Marasas WF, Riley RT, Hendricks KA, et al. (2004). Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: A potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutr 134:711–16
   PubMed Web of Science ®Google Scholar
• Marasas WFO, Kellerman TS, Gelderblom WCA, et al. (1988). Leukoencephalomalacia in a horse induced by fumonisin B1 isolated from Fusarium moniliforme. Onderstepoort J Vet Res 55:197–203
   PubMed Web of Science ®Google Scholar
• McRonald FE, Morris MR, Gentle D, et al. (2009). CpG methylation profiling in vhl related and VHL unrelated renal cell carcinoma. Mol Cancer 8:1–11
   PubMedGoogle Scholar
• Methyl Primer Express Software 1. Applied Biosystems (Designed and created by M.F. Fraga, C. Ferrero, M. Esteller)
   Google Scholar
• Mobio TA, Anane R, Baudrimont I, et al. (2000). Epigenetic properties of fumonisin B(1): Cell cycle arrest and DNA base modification in C6 glioma cells. Toxicol Appl Pharmacol 164:91–6
   PubMed Web of Science ®Google Scholar
• Mobio TA, Tavan E, Baudrimont I, et al. (2003). Comparative study of the toxic effects of fumonisin B1 in rat C6 glioma cells and p53-null mouse embryo fibroblasts. Toxicology 183:65–75
   PubMed Web of Science ®Google Scholar
• Moggs JG, Goodman JI, Trosko JE, Roberts RA. (2004). Epigenetics and cancer: Implications for drug discovery and safety assessment. Toxicol Appl Pharmacol 196:422–30
   PubMed Web of Science ®Google Scholar
• Müller S, Dekant W, Mally A. (2012). Fumonisin B1 and the kidney: Modes of action for renal tumor formation by fumonisin B1 in rodents. Food Chem Toxicol 50:3833–46
   PubMed Web of Science ®Google Scholar
• Niwa T, Yamashita S, Tsukamoto T, et al. (2005). Whole-genome analyses of loss of heterozygosity and methylation analysis of four tumor-suppressor genes in N-methyl-N′-nitro-N-nitrosoguanidine-induced rat stomach carcinomas. Cancer Sci 96:409–13
   PubMed Web of Science ®Google Scholar
• Norred WP, Plattner RD, Vesonder RF, et al. (1992). Effects of selected secondary metabolites of Fusarium moniliforme on unscheduled synthesis of DNA by rat primary hepatocytes. Food Chem Toxicol 30:233–7
   PubMed Web of Science ®Google Scholar
• National Toxicology Program. (2001). Toxicology and carcinogenesis studies of fumonisin B1 (CAS no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser 496:1–352
   PubMedGoogle Scholar
• Pellanda H, Forges T, Bressenot A, et al. (2012). Fumonisin FB1 treatment acts synergistically with methyl donor deficiency during rat pregnancy to produce alterations of H3- and H4-histone methylation patterns in fetuses. Mol Nutr Food Res 56:976–85
   PubMed Web of Science ®Google Scholar
• Pereira MA, Wang W, Kramer PM, Tao L. (2004). DNA hypomethylation induced by non-genotoxic carcinogens in mouse and rat colon. Cancer Lett 212:145–51
   PubMed Web of Science ®Google Scholar
• Pogribny IP, Tryndyak VP, Boureiko A, et al. (2008). Mechanisms of peroxisome proliferator-induced DNA hypomethylation in rat liver. Mutat Res 644:17–23
   PubMed Web of Science ®Google Scholar
• Rasoulpour RJ, LeBaron MJ, Ellis-Hutchings RG, et al. (2011). Epigenetic screening in product safety assessment: Are we there yet? Toxicol Mech Methods 21:298–311
   PubMed Web of Science ®Google Scholar
• Riley RT, Enongene E, Voss KA, et al. (2001). Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ Health Perspect 109:301–8
   PubMed Web of Science ®Google Scholar
• Riley RT, Hinton DM, Chamberlain WJ, et al. (1994). Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague–Dawley rats: A new mechanism of nephrotoxicity. J Nutr 124:594–603
   PubMed Web of Science ®Google Scholar
• Stevens VL, Tang J. (1997). Fumonisin B1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinosotol-anchored folate uptake. J Biol Chem 272:18020–5
   PubMed Web of Science ®Google Scholar
• Stockmann-Juvala H, Mikkola J, Naarala J, et al. (2004). Oxidative stress induced by fumonisin B1 in continuous human and rodent neural cell cultures. Free Radic Res 38:933–42
   PubMed Web of Science ®Google Scholar
• Stockmann-Juvala H, Savolainen K. (2008). A review of the toxic effects and mechanisms of action of fumonisin B1. Hum Exp Toxicol 27:799–809
   PubMed Web of Science ®Google Scholar
• Swafford DS, Middleton SK, Palmisano WA, et al. (1997). Frequent aberrant methylation of p16INK4a in primary rat lung tumors. Mol Cell Biol 17:1366–74
   PubMed Web of Science ®Google Scholar
• Sydenham EW, Thiel PG, Marasas WFO, et al. (1990). Natural occurrence of some Fusarium mycotoxins in corn from low and high esophageal cancer prevalence areas of the Transkei, southern Africa. J Agric Food Chem 38:1900–3
   Web of Science ®Google Scholar
• Voss KA, Chamberlain WJ, Bacon CW, et al. (1995). Subchronic feeding study of the mycotoxin fumonisin B1 in B6C3F1 mice and Fischer 344 rats. Fundam Appl Toxicol 24:102–10
   PubMedGoogle Scholar
• Watson RE, Goodman JI. (2002). Epigenetics and DNA methylation come of age in toxicology. Toxicol Sci 67:11–16
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2002). Evaluation of Certain Mycotoxins in Food. Fifty-sixth Report of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Technical Report 906:16–27
   Google Scholar
• Yu MU, Yoo JM, Lee YS, et al. (2004). Altered de novo sphingolipid biosynthesis is involved in the serum deprivation-induced cell death in LLC-PK1 cells. J Toxicol Environ Health A 67:2085–94
   PubMed Web of Science ®Google Scholar